Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The trial moved semaglutide from a weight loss tool into a recognised cardiovascular risk reduction therapy
For more information, please contact us or book an appointment
Around 3,800 participants were enrolled across both trials, randomized to placebo or oral semaglutide 14 mg daily for up to 104 weeks (~2 years)
The active ingredient is semaglutide, a type of glucagon-like peptide-1 (GLP-1) receptor agonist, used for weight loss
Glucagonlike peptide1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes
You can take them concurrently without concern about reduced effectiveness of either medication
US$ 27.38
US$ 21.98
US$ 20.21
US$ 29.91
US$ 26.54
US$ 26.25
